• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种有助于跨多单元操作制药过程设计空间开发的新型框架——以皂苷速释片为例

A Novel Framework to Aid the Development of Design Space across Multi-Unit Operation Pharmaceutical Processes-A Case Study of Saponins Immediate Release Tablet.

作者信息

Sun Fei, Xu Bing, Dai Shengyun, Zhang Yi, Lin Zhaozhou, Qiao Yanjiang

机构信息

Guangdong Pharmaceutical University, Guangzhou 510006, China.

Research Center of Traditional Chinese Medicine Information Engineering, Beijing University of Chinese Medicine, Beijing 100029, China.

出版信息

Pharmaceutics. 2019 Sep 13;11(9):474. doi: 10.3390/pharmaceutics11090474.

DOI:10.3390/pharmaceutics11090474
PMID:31540243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6781312/
Abstract

The fundamental principle of Quality by Design (QbD) is that the product quality should be designed into the process through an upstream approach, rather than be tested in the downstream. The keystone of QbD is process modeling, and thus, to develop a process control strategy based on the development of design space. Multivariate statistical analysis is a very useful tool to support the implementation of QbD in pharmaceutical process development and manufacturing. Nowadays, pharmaceutical process modeling is mainly focused on one-unit operations and system modeling for the development of design space across multi-unit operations is still limited. In this study, a general procedure that gives a holistic view for understanding and controlling the process settings for the entire manufacturing process was investigated. The proposed framework was tested on the Saponins immediate release tablet (PNS IRT) production process. The critical variables and the critical units acting on the process were identified according to the importance of explaining the variability in the multi-block partial least squares path model. This improved understanding of the process by illustrating how the properties of the raw materials, the process parameters in the wet granulation and the compaction and the intermediate properties affect the tablet properties. Furthermore, the design space was developed to compensate for the variability source from the upstream. The results demonstrated that the proposed framework was an important tool to gain understanding and control the multi-unit operation process.

摘要

质量源于设计(QbD)的基本原则是,产品质量应通过上游方法设计到工艺中,而不是在下游进行测试。QbD的关键是工艺建模,因此,要基于设计空间的开发来制定工艺控制策略。多变量统计分析是支持QbD在制药工艺开发和生产中实施的非常有用的工具。如今,制药工艺建模主要集中在单一单元操作上,而跨多单元操作的设计空间开发的系统建模仍然有限。在本研究中,研究了一种能对整个制造过程的工艺设置进行理解和控制的整体视图的通用程序。所提出的框架在人参皂苷速释片(PNS IRT)生产工艺上进行了测试。根据多块偏最小二乘路径模型中解释变异性的重要性,确定了作用于该工艺的关键变量和关键单元。通过说明原材料的特性、湿法制粒和压片中的工艺参数以及中间特性如何影响片剂特性,提高了对该工艺的理解。此外,开发了设计空间以补偿上游的变异性来源。结果表明,所提出的框架是理解和控制多单元操作过程的重要工具。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/78892cc7c8d7/pharmaceutics-11-00474-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/4baa8c64f3e9/pharmaceutics-11-00474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/8344995f6b91/pharmaceutics-11-00474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/084fb7da7aa6/pharmaceutics-11-00474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/4fb3c2df2136/pharmaceutics-11-00474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/c22b3fb9d5e2/pharmaceutics-11-00474-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/a24d017543f8/pharmaceutics-11-00474-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/324ac0044bd5/pharmaceutics-11-00474-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/73e5cee4a368/pharmaceutics-11-00474-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/0852819703f5/pharmaceutics-11-00474-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/51c57cfc36ad/pharmaceutics-11-00474-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/daee82931f7e/pharmaceutics-11-00474-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/d791aca4721e/pharmaceutics-11-00474-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/78892cc7c8d7/pharmaceutics-11-00474-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/4baa8c64f3e9/pharmaceutics-11-00474-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/8344995f6b91/pharmaceutics-11-00474-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/084fb7da7aa6/pharmaceutics-11-00474-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/4fb3c2df2136/pharmaceutics-11-00474-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/c22b3fb9d5e2/pharmaceutics-11-00474-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/a24d017543f8/pharmaceutics-11-00474-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/324ac0044bd5/pharmaceutics-11-00474-g007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/73e5cee4a368/pharmaceutics-11-00474-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/0852819703f5/pharmaceutics-11-00474-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/51c57cfc36ad/pharmaceutics-11-00474-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/daee82931f7e/pharmaceutics-11-00474-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/d791aca4721e/pharmaceutics-11-00474-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0519/6781312/78892cc7c8d7/pharmaceutics-11-00474-g013.jpg

相似文献

1
A Novel Framework to Aid the Development of Design Space across Multi-Unit Operation Pharmaceutical Processes-A Case Study of Saponins Immediate Release Tablet.一种有助于跨多单元操作制药过程设计空间开发的新型框架——以皂苷速释片为例
Pharmaceutics. 2019 Sep 13;11(9):474. doi: 10.3390/pharmaceutics11090474.
2
Statistical modeling methods to analyze the impacts of multiunit process variability on critical quality attributes of Chinese herbal medicine tablets.用于分析多单元过程变异性对中药片剂关键质量属性影响的统计建模方法。
Drug Des Devel Ther. 2016 Nov 28;10:3909-3924. doi: 10.2147/DDDT.S119122. eCollection 2016.
3
[System modeling on Chinese herbal medicine process based on multi-block partial least squares].基于多块偏最小二乘法的中药过程系统建模
Zhongguo Zhong Yao Za Zhi. 2018 Aug;43(16):3270-3278. doi: 10.19540/j.cnki.cjcmm.20180611.008.
4
Q-marker based strategy for CMC research of Chinese medicine: A case study of Panax Notoginseng saponins.基于 Q 标志物的中药 CMC 研究策略:以三七总皂苷为例。
Phytomedicine. 2018 May 15;44:129-137. doi: 10.1016/j.phymed.2018.01.023. Epub 2018 Jan 31.
5
Optimal Selection of Incoming Materials from the Inventory for Achieving the Target Drug Release Profile of High Drug Load Sustained-Release Matrix Tablet.最优选择库存来料以实现高载药量缓控释骨架片的目标药物释放特征。
AAPS PharmSciTech. 2019 Jan 11;20(2):76. doi: 10.1208/s12249-018-1268-9.
6
Setting up multivariate specifications on critical raw material attributes to ensure consistent drug dissolution from high drug-load sustained-release matrix tablet.建立关键原材料属性的多元规范,以确保高载药量缓控释骨架片的药物溶出度一致。
Drug Dev Ind Pharm. 2018 Nov;44(11):1733-1743. doi: 10.1080/03639045.2018.1492608. Epub 2018 Sep 3.
7
Pharmaceutical quality by design: product and process development, understanding, and control.药品质量源于设计:产品与工艺开发、理解及控制
Pharm Res. 2008 Apr;25(4):781-91. doi: 10.1007/s11095-007-9511-1. Epub 2008 Jan 10.
8
General procedure to aid the development of continuous pharmaceutical processes using multivariate statistical modeling - an industrial case study.使用多元统计建模辅助连续制药工艺开发的一般程序 - 工业案例研究。
Int J Pharm. 2013 Feb 28;444(1-2):25-39. doi: 10.1016/j.ijpharm.2013.01.018. Epub 2013 Jan 18.
9
Chromatographic elution process design space development for the purification of saponins in Panax notoginseng extract using a probability-based approach.基于概率方法的三七提取物中皂苷纯化的色谱洗脱过程设计空间开发
J Sep Sci. 2016 Jan;39(2):306-15. doi: 10.1002/jssc.201500976. Epub 2015 Dec 15.
10
Modeling the effects of material properties on tablet compaction: A building block for controlling both batch and continuous pharmaceutical manufacturing processes.建立片剂压缩中材料性能影响的模型:控制批处理和连续制药过程的基石。
Int J Pharm. 2018 May 30;543(1-2):274-287. doi: 10.1016/j.ijpharm.2018.03.036. Epub 2018 Mar 20.

引用本文的文献

1
Understanding of Wetting Mechanism Toward the Sticky Powder and Machine Learning in Predicting Granule Size Distribution Under High Shear Wet Granulation.理解高剪切湿法制粒过程中粘性粉末的润湿机理及基于机器学习预测颗粒粒度分布。
AAPS PharmSciTech. 2024 Oct 23;25(8):253. doi: 10.1208/s12249-024-02973-w.
2
Pharmaceutical application of multivariate modelling techniques: a review on the manufacturing of tablets.多元建模技术的药学应用:片剂制造综述
RSC Adv. 2021 Feb 23;11(14):8323-8345. doi: 10.1039/d0ra08030f. eCollection 2021 Feb 17.
3
In-Depth Understanding of Granule Compression Behavior under Variable Raw Material and Processing Conditions.

本文引用的文献

1
Near infrared spectroscopy: A mature analytical technique with new perspectives - A review.近红外光谱学:具有新视角的成熟分析技术 - 综述。
Anal Chim Acta. 2018 Oct 5;1026:8-36. doi: 10.1016/j.aca.2018.04.004. Epub 2018 Apr 17.
2
Lubricant based determination of design space for continuously manufactured high dose paracetamol tablets.基于润滑剂的高剂量对乙酰氨基酚连续制造片剂设计空间的确定。
Eur J Pharm Sci. 2018 Mar 30;115:1-10. doi: 10.1016/j.ejps.2017.12.021. Epub 2017 Dec 24.
3
Mapping the pharmaceutical design space by amorphous ionic liquid strategies.
深入了解可变原料和加工条件下颗粒的压缩行为
Pharmaceutics. 2022 Jan 12;14(1):177. doi: 10.3390/pharmaceutics14010177.
4
Effect of Spray Drying Conditions on Physical Properties of Saponin (PNS) Powder and the Intra-Batch Dissolution Variability of PNS Hydrophilic Matrix Tablet.喷雾干燥条件对人参总皂苷(PNS)粉末物理性质及 PNS 亲水性骨架片批内溶出度变异性的影响。
Drug Des Devel Ther. 2021 Mar 30;15:1425-1440. doi: 10.2147/DDDT.S295825. eCollection 2021.
5
Quality Assessment of Different Species and Differently Prepared Slices of Zedoray Rhizome by High-Performance Liquid Chromatography and Colorimeter with the Aid of Chemometrics.基于化学计量学的高效液相色谱法和比色计对不同品种及不同炮制方法莪术饮片的质量评价
J Anal Methods Chem. 2020 Sep 29;2020:8866250. doi: 10.1155/2020/8866250. eCollection 2020.
6
Working within the Design Space: Do Our Static Process Characterization Methods Suffice?在设计空间内工作:我们的静态工艺表征方法是否足够?
Pharmaceutics. 2020 Jun 17;12(6):562. doi: 10.3390/pharmaceutics12060562.
通过无定形离子液体策略绘制药物设计空间。
J Control Release. 2017 Dec 28;268:314-322. doi: 10.1016/j.jconrel.2017.10.040. Epub 2017 Oct 31.
4
Quantitative risk assessment via uncertainty analysis in combination with error propagation for the determination of the dynamic Design Space of the primary drying step during freeze-drying.通过不确定性分析与误差传播相结合的定量风险评估,确定冷冻干燥过程中主干燥步骤的动态设计空间。
Eur J Pharm Biopharm. 2017 Dec;121:32-41. doi: 10.1016/j.ejpb.2017.08.015. Epub 2017 Sep 18.
5
The future of pharmaceutical quality and the path to get there.药品质量的未来以及实现这一目标的途径。
Int J Pharm. 2017 Aug 7;528(1-2):354-359. doi: 10.1016/j.ijpharm.2017.06.039. Epub 2017 Jun 12.
6
Modeling in the quality by design environment: Regulatory requirements and recommendations for design space and control strategy appointment.在质量源于设计环境下建模:设计空间和控制策略指定的监管要求和建议。
Int J Pharm. 2017 Nov 30;533(2):346-356. doi: 10.1016/j.ijpharm.2017.05.070. Epub 2017 Jun 1.
7
Statistical modeling methods to analyze the impacts of multiunit process variability on critical quality attributes of Chinese herbal medicine tablets.用于分析多单元过程变异性对中药片剂关键质量属性影响的统计建模方法。
Drug Des Devel Ther. 2016 Nov 28;10:3909-3924. doi: 10.2147/DDDT.S119122. eCollection 2016.
8
Uncertainty analysis as essential step in the establishment of the dynamic Design Space of primary drying during freeze-drying.不确定性分析是冻干过程中一次干燥动态设计空间确立的关键步骤。
Eur J Pharm Biopharm. 2016 Jun;103:71-83. doi: 10.1016/j.ejpb.2016.03.015. Epub 2016 Mar 15.
9
Latent structure analysis in the pharmaceutical process of tablets prepared by wet granulation.湿法制粒制备片剂的制药过程中的潜在结构分析。
Drug Dev Ind Pharm. 2016 Jan;42(1):116-122. doi: 10.3109/03639045.2015.1035281. Epub 2015 May 22.
10
Understanding pharmaceutical quality by design.理解药物质量源于设计。
AAPS J. 2014 Jul;16(4):771-83. doi: 10.1208/s12248-014-9598-3. Epub 2014 May 23.